Table 1.
PSI group (n = 20) | Control group (n = 21) | P-value | |
---|---|---|---|
Gender (F/M) | 11 / 9 | 9/ 12 | 0.44 |
Age (yr) | 49.85 ± 11.80 | 43.90 ± 12.14 | 0.12 |
Weight (kg) | 60.9 ± 11.46 | 66.60 ± 11.12 | 0.11 |
Height (cm) | 162.60 ± 6.10 | 165.29 ± 6.75 | 0.19 |
ASA class (I/II) | 8 / 12 | 13 / 8 | 0.16 |
Preoperative NRS | 0.75 ± 0.44 (5.01) | 0.62 ± 0.50 | 0.37 |
Duration of surgery (min) | 118.50 ± 40.50 | 110.71 ± 27.99 | 0.48 |
Duration of anesthesia (min) | 145.50 ± 40.84 | 137.62 ± 28.97 | 0.48 |
Total sufentanil (μg) | 27.75 ± 4.72 | 28.57 ± 5.73 | 0.62 |
Total remifentanil (μg) | 710.00 ± 228.61 | 704.76 ± 160.39 | 0.93 |
Operative blood loss (mL) | 200.00 ± 79.47 | 200.00 ± 75.83 | 1.00 |
Intra-operative fluids (mL) | 1677.50 ± 443.81 | 1514.29 ± 304.20 | 0.18 |
Urine output (mL) | 545.00 ± 229.93 | 476.19 ± 210.13 | 0.32 |
Histopathological diagnosis (Thymoma/Lymphoma/Other) | 13 / 3 / 4 | 13 / 4 / 4 | 0.94 |
Data are mean ± standard deviation or number (proportion) of patients